Substance | Relationship Strength | Studies | Trials | Classes | Roles |
acetylcarnitine Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS. | 2.68 | 3 | 0 | O-acylcarnitine | human metabolite |
betaine glycine betaine : The amino acid betaine derived from glycine. | 1.98 | 1 | 0 | amino-acid betaine; glycine derivative | fundamental metabolite |
carnitine [no description available] | 7.1 | 26 | 1 | amino-acid betaine | human metabolite; mouse metabolite |
gamma-butyrobetaine 4-(trimethylammonio)butanoate : An amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups. | 1.98 | 1 | 0 | amino-acid betaine | Escherichia coli metabolite; human metabolite |
glycine [no description available] | 2.11 | 1 | 0 | alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical |
clofibrate angiokapsul: contains clofibrate & insoitolnicotinate | 6.98 | 1 | 0 | aromatic ether; ethyl ester; monochlorobenzenes | anticholesteremic drug; antilipemic drug; geroprotector; PPARalpha agonist |
valproic acid Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.. valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem. | 7.44 | 2 | 0 | branched-chain fatty acid; branched-chain saturated fatty acid | anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent |
ampicillin Ampicillin: Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.. ampicillin : A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group. | 6.97 | 1 | 0 | beta-lactam antibiotic; penicillin allergen; penicillin | antibacterial drug |
pivalic acid pivalic acid: RN given refers to parent cpd; structure. pivalic acid : A branched, short-chain fatty acid composed of propanoic acid having two methyl substituents at the 2-position. | 11.74 | 18 | 1 | branched-chain saturated fatty acid; methyl-branched fatty acid; short-chain fatty acid | |
quinoxalines quinoxaline : A naphthyridine in which the nitrogens are at positions 1 and 4. | 1.98 | 1 | 0 | mancude organic heterobicyclic parent; naphthyridine; ortho-fused heteroarene | |
isovaleric acid isovaleric acid: structure. isovaleric acid : A C5, branched-chain saturated fatty acid. | 6.99 | 1 | 0 | branched-chain saturated fatty acid; methylbutyric acid; short-chain fatty acid | mammalian metabolite; plant metabolite |
pivampicillin Pivampicillin: Pivalate ester analog of AMPICILLIN.. pivampicillin : A penicillanic acid ester that is the pivaloyloxymethyl ester of ampicillin. It is a prodrug of ampicillin. | 7.67 | 3 | 0 | penicillanic acid ester; pivaloyloxymethyl ester | prodrug |
s-adenosylmethionine acylcarnitine: structure in first source. S-adenosyl-L-methioninate : A sulfonium betaine that is a conjugate base of S-adenosyl-L-methionine obtained by the deprotonation of the carboxy group. | 3.35 | 6 | 0 | sulfonium betaine | human metabolite |
cephalosporin c cephalosporin C: RN given refers to parent cpd; structure in Merck, 9th ed, #1937. cephalosporin C : A cephalosporin antibiotic carrying a 3-acetoxymethyl substituent and a 6-oxo-N(6)-L-lysino group at position 7. | 4.47 | 5 | 1 | cephalosporin | fungal metabolite |
sivelestat sivelestat: inhibitor of neutrophil elastase; structure given in first source | 7.11 | 1 | 0 | N-acylglycine; pivalate ester | |
valproylcarnitine [no description available] | 7.44 | 2 | 0 | | |
sulbactam [no description available] | 1.99 | 1 | 0 | penicillanic acids | |
isobutyryl-1-carnitine O-isobutyryl-L-carnitine : An optically active form of O-isobutyrylcarnitine having (R)-configuration. | 2.05 | 1 | 0 | methyl-branched fatty acyl-L-carnitine; O-isobutyrylcarnitine; saturated fatty acyl-L-carnitine | human metabolite |
butyrylcarnitine butyrylcarnitine: structure in first source. O-butanoyl-L-carnitine : An optically active form of O-butanoylcarnitine having L-configuration.. O-butanoylcarnitine : A C4-acylcarnitine that is the O-butanoyl derivative of carnitine. | 2.05 | 1 | 0 | O-butanoylcarnitine; saturated fatty acyl-L-carnitine | metabolite |
s 1108 S 1108: structure given in first source; an oral cephem antibiotic and prodrug of S-1006 | 4.06 | 3 | 1 | | |
cefteram pivoxil cefteram pivoxil: structure given in first source | 1.98 | 1 | 0 | 1,3-thiazoles; cephams; oxime O-ether; pivaloyloxymethyl ester; tetrazoles | |
3-methylbutyrylcarnitine 3-methylbutyrylcarnitine: affects 2-oxo acid dehydrogenase activity in intact mitochondria of rat muscle; RN given refers to (R)-isomer. O-isovalerylcarnitine : A C5-acylcarnitine having isovaleryl as the acyl substituent. | 2.43 | 2 | 0 | C5-acylcarnitine | human metabolite |
s 1006 S 1006: structure given in first source. cefcapene : A cephalosporin compound having (carbamoyloxy)methyl and N-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino side-groups. It is used (generally as the corresponnding pivaloyloxymethyl ester prodrug) as an oral antibacterial. | 3.77 | 2 | 1 | 1,3-thiazoles; carbamate ester; carboxylic acid; cephalosporin; enamide; secondary carboxamide | antibacterial drug |
cefmenoxime Cefmenoxime: A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.. cefmenoxime : A third-generation cephalosporin antibiotic, bearing a 2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino group at the 7beta-position and a [(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl group at the 3-position. | 1.98 | 1 | 0 | cephalosporin | antibacterial drug |